Trials / Conditions / Second-line Therapy
Second-line Therapy
3 registered clinical trials studyying Second-line Therapy — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and NCT07343453 | Sun Yat-sen University | Phase 2 |
| Recruiting | Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer NCT07320586 | Shandong Tumor Hospital | Phase 2 |
| Unknown | Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagoga NCT04713059 | The Affiliated Hospital of Qingdao University | — |